DynamiCardio Competitors

Teladoc, Inc. (NYSE: TDOC) is the nation’s first and largest telehealth platform, delivering on-demand health care anytime, from almost anywhere via mobile devices, the Internet, secure video and phone. Teladoc provides health plans, employers, organizations and individuals with access to its network of more than 3,000 board-certified, state-licensed physicians and behavioral health professionals who provide care for a wide range of non-emergency conditions. Recognized in June 2015 by MIT Technology Review as one of the “50 Smartest Companies,” Teladoc is transforming the access, cost and quality dynamics of health care delivery. For more information, please visit teladoc.com, twitter.com/teladoc, facebook.com/teladoc or linkedin.com/teladoc.

Teladoc Health is the global leader in virtual care, delivering and orchestrating care across patients, care providers, platforms and partners – transforming virtual care into a catalyst for how better health happens. Our comprehensive care offerings span primary care, mental health, chronic condition management and more, all integrated on a single platform. We partner with employers, health plans, hospitals, health systems and other providers to fuel clinical excellence and apply the power of technology to help people live their healthiest lives. Follow us for industry insights, virtual care trends, client success stories and expert perspectives shaping the future of healthcare. For more information, please visit www.teladochealth.com or follow @TeladocHealth on X.

Heartflow is the global leader in AI-driven coronary artery disease (CAD) management, transforming how CAD — the world’s leading cause of death — is diagnosed and treated. Our advanced technology generates personalized, precision 3D heart models from a single CT scan, providing clinicians with the clarity and confidence to deliver earlier, more effective treatments — transforming CAD into a disease that can be managed for life. Heartflow One is the only complete, non-invasive, precision coronary care platform providing patient insights throughout the guideline-directed coronary CTA pathway. The AI-driven platform — including Roadmap™ Analysis, FFRct Analysis and Plaque Analysis — is supported by ACC/AHA guidelines and backed by more than 625 peer-reviewed publications. With over 650,000 patients treated, more than 1,800 leading institutions adopting our solution, and 99.5% of U.S. lives covered — Heartflow is redefining the standard of coronary care. We're a global company, with employees across the United States, Europe and Japan. Our headquarters are in San Francisco, California, with additional offices in California, Texas, the UK and Japan. We believe CAD shouldn’t be a silent threat. We’re changing the story of CAD by making it screenable, diagnosable, and manageable — empowering clinicians to save lives and giving patients more time for what matters most.